Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion

FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

 
comments powered by Disqus